Finance

Lists
Why is IBT-B up 6.30%?
Dive Deeper
IBT-B:STO
Infant Bacterial Therapeutics AB
SEK 74.20
+6.30%
(+4.40) 1D
Oct 7, 5:29:45 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for IBT-B...
Open
SEK 69.90
High
SEK 74.50
Low
SEK 69.80
Mkt. cap
949.37M
Avg. vol.
9.41K
Volume
26.95K
52-wk high
SEK 76.10
52-wk low
SEK 43.25
EPS
-SEK 6.08
Shares outstanding
13.02M
No. of employees
6
Open
SEK 69.90
High
SEK 74.50
Low
SEK 69.80
Mkt. cap
949.37M
Avg. vol.
9.41K
Volume
26.95K
52-wk high
SEK 76.10
52-wk low
SEK 43.25
EPS
-SEK 6.08
Shares outstanding
13.02M
No. of employees
6
News stories
From web sources and news partners
About Infant Bacterial Therapeutics AB
CEOStaffan Strömberg
Employees6
Founded2011
Headquarters-
SectorPharmaceutical industry
Websiteibtherapeutics.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.01M
15.66M
18.69M
23.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.83M
4.88M
4.81M
7.09M
Operating expense
10.84M
20.54M
23.50M
30.11M
Total operating expenses
10.84M
20.54M
23.50M
30.11M
Operating income
-10.84M
-20.54M
-23.50M
-30.11M
Other non operating income
1.00K
-1.00K
-563.44M
-
EBT including unusual items
-10.05M
-19.20M
-22.94M
-29.73M
EBT excluding unusual items
-10.05M
-19.20M
-22.94M
-29.73M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10.05M
-19.20M
-22.94M
-29.73M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
784.00K
1.34M
564.00M
380.00K
Interest expense
-
-
-
-
Net interest expenses
784.00K
1.34M
564.00M
380.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps